Trial Profile

A real-life experience study of metastatic urothelial carcinoma patients treated with atezolizumab

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Atezolizumab (Primary)
Indications Carcinoma; Urogenital cancer
Focus Therapeutic Use

Most Recent Events

13 Feb 2021 Results (n=105) presented at the 2021 Genitourinary Cancers Symposium
21 Sep 2020 Results (n=113) assessing prognostic factors association with overall survival presented at the 45th European Society for Medical Oncology Congress
26 Mar 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com